MoneyWorks4Me

Astrazeneca Pharma I - Quaterly Results

30 May 2023 Evaluate
The revenue for the March 2023 quarter is pegged at Rs. 2847.03 millions, about 22.74% up against Rs. 2319.63 millions recorded during the year-ago period.The Company to register a -38.28%  fall in the net profit for the quarter ended March 2023.OP of the company witnessed a marginal growth to 678.46 millions from 416.45 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 2847.03 2319.63 22.74 10029.71 8056.00 24.50 10029.71 8056.00 24.50
Other Income 79.97 36.84 117.07 261.02 147.58 76.87 261.02 147.58 76.87
PBIDT 678.46 416.45 62.92 1914.27 1009.33 89.66 1914.27 1009.33 89.66
Interest 0.88 2.07 -57.49 8.33 9.47 -12.04 8.33 9.47 -12.04
PBDT 275.29 414.38 -33.57 1503.65 999.86 50.39 1503.65 999.86 50.39
Depreciation 42.49 44.07 -3.59 162.60 169.49 -4.07 162.60 169.49 -4.07
PBT 232.80 370.31 -37.13 1341.05 830.37 61.50 1341.05 830.37 61.50
TAX 60.09 90.47 -33.58 348.12 214.43 62.35 348.12 214.43 62.35
Deferred Tax -23.73 -1.67 1320.96 -34.90 -11.86 194.27 -34.90 -11.86 194.27
PAT 172.71 279.84 -38.28 992.93 615.94 61.21 992.93 615.94 61.21
Equity 50.00 50.00 0.00 50.00 50.00 0.00 50.00 50.00 0.00
PBIDTM(%) 23.83 17.95 32.74 19.09 12.53 52.34 19.09 12.53 52.34
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..